Correlation Between Powerchip Semiconductor and Synmosa Biopharma

Can any of the company-specific risk be diversified away by investing in both Powerchip Semiconductor and Synmosa Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Powerchip Semiconductor and Synmosa Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Powerchip Semiconductor Manufacturing and Synmosa Biopharma, you can compare the effects of market volatilities on Powerchip Semiconductor and Synmosa Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Powerchip Semiconductor with a short position of Synmosa Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Powerchip Semiconductor and Synmosa Biopharma.

Diversification Opportunities for Powerchip Semiconductor and Synmosa Biopharma

-0.45

Correlation Coefficient

Powerchip Semiconductor  Synmosa Biopharma

Very good diversification

The 3 months correlation between Powerchip and Synmosa is -0.45. Overlapping area represents the amount of risk that can be diversified away by holding Powerchip Semiconductor Manufa and Synmosa Biopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Synmosa Biopharma and Powerchip Semiconductor is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Powerchip Semiconductor Manufacturing are associated (or correlated) with Synmosa Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Synmosa Biopharma has no effect on the direction of Powerchip Semiconductor i.e., Powerchip Semiconductor and Synmosa Biopharma go up and down completely randomly.

Pair Corralation between Powerchip Semiconductor and Synmosa Biopharma

Assuming the 90 days trading horizon Powerchip Semiconductor Manufacturing is expected to generate 4.07 times more return on investment than Synmosa Biopharma. However, Powerchip Semiconductor is 4.07 times more volatile than Synmosa Biopharma. It trades about 0.04 of its potential returns per unit of risk. Synmosa Biopharma is currently generating about -0.02 per unit of risk. If you would invest  1,655  in Powerchip Semiconductor Manufacturing on December 27, 2024 and sell it today you would earn a total of  65.00  from holding Powerchip Semiconductor Manufacturing or generate 3.93% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Powerchip Semiconductor Manufa  vs.  Synmosa Biopharma

Powerchip Semiconductor

Risk-Adjusted Performance

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Powerchip Semiconductor Manufacturing are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, Powerchip Semiconductor may actually be approaching a critical reversion point that can send shares even higher in April 2025.

Synmosa Biopharma

Risk-Adjusted Performance

Very Weak

Over the last 90 days Synmosa Biopharma has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable basic indicators, Synmosa Biopharma is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.

Pair Trading with Powerchip Semiconductor and Synmosa Biopharma

The main advantage of trading using opposite Powerchip Semiconductor and Synmosa Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Powerchip Semiconductor position performs unexpectedly, Synmosa Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Synmosa Biopharma will offset losses from the drop in Synmosa Biopharma's long position.

The idea behind Powerchip Semiconductor Manufacturing and Synmosa Biopharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.